Skip to content
Trial Eligibility
Menu

A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation

NCT06234969

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). The investigators will demonstrate that IPS cTBS results in significant reduction in arousal (measured by startle response) compared to sham cTBS, that IPS cTBS interacts with extinction training to further improve arousal, and that there is a dose/response effect of cTBS on arousal.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Posttraumatic Stress Disorder

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 60 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Pennsylvania
Last updated on ClinicalTrials.gov
October 30, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • Center for the Treatment and Study of Anxiety, University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.